CVS Health (CVS) is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the US in 2026, including a new Roxbury site in the Boston area.
Recent headlines around CVS Health have mixed signals for investors, with Medicare Advantage star rating setbacks and a legal probe weighing on sentiment, while the extended Cardinal Health distribution deal and a reaffirmed dividend provide a steadier backdrop.
Even after a one-day share price decline of 1.87% and a 30-day share price return down 8.98%, the year-to-date share price return of 7.53% and a one-year total shareholder return of 14.11% indicate that longer term holders have still seen gains as shorter term momentum has faded.
Spot 29 high quality undervalued stocks that, like CVS Health, combine sizeable healthcare exposure with established cash generation and could be setting up for the next phase of their rerating.
That mix of headline pressure and steady cash generation has hit CVS Health’s share price, but sentiment can move faster than fundamentals. Is this pullback a reset of expectations, or a misread of what the business is worth?
Most Popular Narrative: 31% Undervalued
On the most followed view, CVS Health screens as undervalued, with a fair value of $124 against a last close of $86.16, which frames the latest pullback as more than just headline fatigue.
CVS Health is no longer the broken-Aetna-plus-drugstore story the market used for most of 2024 to 2025. Through the first half of 2026 the company has raised full-year guidance twice, Aetna’s medical benefit ratio has improved, cash flow is running well ahead of plan, and all three operating segments are growing. The stock still trades as if the insurance rebuild is temporary and the PBM is about to be regulated into irrelevance.
See why 2 investors see CVS Health as 31% undervalued.
Result: Fair Value of $124 (UNDERVALUED)
Still, the CVS Health story can break if Aetna’s medical cost trend runs hotter than expected, or if pharmacy benefit reforms compress Health Services earnings faster than planned.
Find out about the key risks to this CVS Health narrative.
Next Steps
Sentiment on CVS Health is clearly split, with meaningful risks on one side and real upside potential on the other. Move quickly and stress test the thesis for yourself by weighing the 4 key rewards and 2 important warning signs.
Looking for more investment ideas beyond CVS Health?
If you want to pressure test your thesis on CVS Health, line it up against other quality opportunities using the Simply Wall Street Screener before the next move.
Source: sg.finance.yahoo.com
